These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2010566)

  • 1. Drug delivery systems 5B. Oral drug delivery.
    Ranade VV
    J Clin Pharmacol; 1991 Feb; 31(2):98-115. PubMed ID: 2010566
    [No Abstract]   [Full Text] [Related]  

  • 2. Ion Exchange Resins Transforming Drug Delivery Systems.
    Gupta S; Benien P; Sahoo PK
    Curr Drug Deliv; 2010 Jul; 7(3):252-62. PubMed ID: 20497105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sampling procedures of release testing on drug release and scale-up production feasibility of multiple-unit dextromethorphan resinate tablets: a technical note.
    Pongjanyakul T
    AAPS PharmSciTech; 2007 Dec; 8(4):E117. PubMed ID: 18181538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ion exchange resins in the formulation of sustained release medication.
    SENSENBACH WE; HAYS EE
    Am J Med Sci; 1960 Oct; 240():474-8. PubMed ID: 13750120
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent trends in oral drug delivery: a review.
    Gupta H; Bhandari D; Sharma A
    Recent Pat Drug Deliv Formul; 2009 Jun; 3(2):162-73. PubMed ID: 19519576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of drugs and vaccines to the gut.
    Wilding IR; Davis SS; O'Hagan DT
    Pharmacol Ther; 1994; 62(1-2):97-124. PubMed ID: 7991649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study, outline and formulation of pharmaceutical preparations with delayed action].
    Arancibia A
    Farmaco Prat; 1972 Apr; 27(4):181-204. PubMed ID: 5022155
    [No Abstract]   [Full Text] [Related]  

  • 8. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of pharmaceutical formulation for drug absorption.
    Sjögren J
    Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():68-80. PubMed ID: 5316412
    [No Abstract]   [Full Text] [Related]  

  • 10. Myfortic (mycophenolate sodium) delayed-release tablets.
    Qureshi A; Scheinfeld N
    Dermatol Online J; 2008 Aug; 14(8):4. PubMed ID: 19061564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulations and dosages of oral drugs.
    Calesnick B
    Am Fam Physician; 1978 Sep; 18(3):160-2. PubMed ID: 685796
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral modified-release formulations in motion: the relationship between gastrointestinal transit and drug absorption.
    Varum FJ; Merchant HA; Basit AW
    Int J Pharm; 2010 Aug; 395(1-2):26-36. PubMed ID: 20546855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of drug release from pellets coated with different shellac types.
    Farag Y; Leopold CS
    Drug Dev Ind Pharm; 2011 Feb; 37(2):193-200. PubMed ID: 21073321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tableting research and technology.
    Cooper J; Rees JE
    J Pharm Sci; 1972 Oct; 61(10):1511-55. PubMed ID: 4561201
    [No Abstract]   [Full Text] [Related]  

  • 15. Mucoadhesive platforms for targeted delivery to the colon.
    Varum FJ; Veiga F; Sousa JS; Basit AW
    Int J Pharm; 2011 Nov; 420(1):11-9. PubMed ID: 21856393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral controlled release preparations.
    García CR; Siqueiros A; Benet LZ
    Pharm Acta Helv; 1978; 53(3-4):99-109. PubMed ID: 360228
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of soybean protein for controlled release of drugs administered orally.
    Machida Y; Tokumura T; Nagai T
    Drug Des Deliv; 1987 Feb; 1(3):179-86. PubMed ID: 3509331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of decrease in both postprandial blood glucose (PBG) and fasting blood glucose (FBG) levels in normal beagle dogs with nateglinide enteric coated granules and immediate release tablets.
    Makino C; Ninomiya N; Sakai H; Orita H; Okano A; Yabuki A
    Chem Pharm Bull (Tokyo); 2006 Apr; 54(4):409-14. PubMed ID: 16595936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral pulsatile delivery: rationale and chronopharmaceutical formulations.
    Maroni A; Zema L; Del Curto MD; Loreti G; Gazzaniga A
    Int J Pharm; 2010 Oct; 398(1-2):1-8. PubMed ID: 20655998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the relationship between in vitro and in vivo release behaviors of acamprosate from enteric-coated tablets.
    Rhee YS; Park S; Lee TW; Park CW; Nam TY; Oh TO; Jeon JW; Lee DS; Park ES
    Arch Pharm Res; 2008 Jun; 31(6):798-804. PubMed ID: 18563364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.